Ropes & Gray represented Sands Capital in leading $100 million in Series D financing for Cytovale, a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases. The funding was announced in an Oct. 10 press release.
Sands Capital is an active, long-term investor in leading innovative businesses globally. The firm managed more than $53.9 billion in client assets as of Sept. 30.
The team was led by venture capital & emerging companies partner Brad Flint.
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.